戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 roviding estimates for 130 distinct populations matched the inclusion criteria.
2                                 In total, 1,710 samples met inclusion criteria.
3 acted and synthesized data from full-text articles that met inclusion criteria.
4                         Among 2,084 patients, 1,289 met the inclusion criteria.
5 rch terms and identified 1928 articles, of which 37 met our inclusion criteria.
6                             A total of 111 articles met our inclusion criteria.
7                      Eighty-four eyes (55 patients) met the inclusion criteria.
8 ional primary studies of multifaceted interventions met the inclusion criteria.
9                          There were 22 958 patients who met inclusion criteria.
10                     Overall, 847 participants met the study inclusion criteria.
11 nd Embase on Nov 7-8, 2018; of 1409 articles, seven met the inclusion criteria.
12 2018, we screened 115 patients, 25 of whom did not meet the inclusion criteria.
13 2); and one shared paper between New Zealand and UK met the inclusion criteria.
14 in our meta-analysis after application of our exclusion and inclusion criteria.
15 aluated at Indiana University between 1990 and 2016 who met inclusion criteria.
16 , 124 articles were assessed in full and 37 studies met the inclusion criteria.
17                     We included 18 128 patients who met the inclusion criteria.
18                     A total of 37,163 individuals met study inclusion criteria; 10.4% were tested by IGRA.
19                          Of 201 patients evaluated, 163 met inclusion criteria: 116 anomalous right CA (71%), 25 anomalou
20                            In total, 407 patients met final inclusion criteria (332 adults, 75 children).
21              Among 1,889,032 Medicare beneficiaries who met inclusion criteria 560,744 (n = 29.7%) individuals had an ant
22    Among 341 individuals screened (11/2016-7/2017), 200 met inclusion criteria; 58% injected drugs and 31% shared needles
23 r (D); in eyes with toric IOL implantation that met certain inclusion criteria, 80%, 84%, and 69% of eyes, respectively,
24 s with (1) tumor burden meeting UNOS down-staging (UNOS-DS) inclusion criteria and (2) "all-comers" (AC-DS) with initial
25       Most of their concerns stem from disagreement on data inclusion criteria and analysis, misunderstanding of our goal
26                                   A total of 35 studies met inclusion criteria and form the evidence base, including 17 s
27                   Desquilbet et al take issue with our data inclusion criteria and make several other dubious claims rega
28 se, 48 were selected for a full-text review, and 13 met the inclusion criteria and were assigned a quality-of-evidence ra
29 s who underwent esophagectomy between 1991 and 2017 who met inclusion criteria and were contactable, responded to the que
30  Of 308 patients with acute neurologic symptoms, 73 met the inclusion criteria and were included (23.7%): thirty-five pat
31                           A total of twelve studies met the inclusion criteria and were included in the review.
32 atabase, Embase, Ovid MEDLINE, and PubMed were searched and inclusion criteria applied.
33    Of 11 336 female CCSS participants, 5886 (51.9%) met all inclusion criteria for analysis.
34                       We identified 89 studies that met our inclusion criteria for the systematic review, and 21 studies
35  with triple-negative breast cancer in the database met the inclusion criteria for this analysis.
36                                     Twenty articles met the inclusion criteria for this assessment and were assigned a le
37  and 15 of the 34 articles selected for full review met all inclusion criteria for this assessment.
38                                                             Inclusion criteria included adult patients with postoperative
39                                                             Inclusion criteria included cases exhibiting marginal gingiva
40                       We identified 41 studies that met our inclusion criteria involving 112,034 patients in total.
41                       Of 128 enrolled, 100 participants met inclusion criteria (mean age, 48.6 years; 41 men).
42  mastocytosis (89 patients with advSM fulfilling the strict inclusion criteria of the D2201 study [ClinicalTrials.gov ide
43 nd one hundred five eyes of 986 AREDS2 participants met the inclusion criteria; of these, 977 participants (99.1%) underw
44 that the model-based selection outperforms the conventional inclusion criteria, reducing by 20-25% the number of patients
45                                                             Inclusion criteria were age >15 years of age with evidence of
46                                                             Inclusion criteria were confirmed HIV infection and age > 18
47                           The data of the women who met the inclusion criteria were linked to the data of their offspring
48                                                         Key inclusion criteria were the absence of high-risk multiple mye
49                                                             Inclusion criteria were: fish bone located beyond the esophag
50  institutional study, 162 patients (7-18 years old) met our inclusion criteria with a mean age of 13.4 years at bone marr